{"id":44813,"date":"2022-06-07T20:01:26","date_gmt":"2022-06-07T18:01:26","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/chromadex-to-present-at-the-oppenheimers-22nd-annual-consumer-growth-and-e-commerce-conference\/"},"modified":"2022-06-07T20:01:26","modified_gmt":"2022-06-07T18:01:26","slug":"chromadex-to-present-at-the-oppenheimers-22nd-annual-consumer-growth-and-e-commerce-conference","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/chromadex-to-present-at-the-oppenheimers-22nd-annual-consumer-growth-and-e-commerce-conference\/","title":{"rendered":"ChromaDex to Present at the Oppenheimer\u2019s 22nd Annual Consumer Growth and E-Commerce Conference"},"content":{"rendered":"<div>\n<p>LOS ANGELES&#8211;(BUSINESS WIRE)&#8211;<a href=\"https:\/\/twitter.com\/search?q=%24CDXC&amp;src=ctag\" target=\"_blank\" rel=\"noopener\">$CDXC<\/a> <a href=\"https:\/\/twitter.com\/hashtag\/Oppenheimer?src=hash\" target=\"_blank\" rel=\"noopener\">#Oppenheimer<\/a>&#8211;ChromaDex Corp. (NASDAQ:CDXC) today announced that its Chief Executive Officer, Rob Fried, and Chief Financial Officer, Kevin Farr, will be presenting at Oppenheimer\u2019s 22<sup>nd<\/sup> Annual Consumer Growth and E-Commerce Conference.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220607006148\/en\/784728\/5\/CDX_logo_horizontal-lrg-01_copy.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220607006148\/en\/784728\/21\/CDX_logo_horizontal-lrg-01_copy.jpg\"><\/a><\/p>\n<p>\nThe ChromaDex management team is scheduled to present virtually on Wednesday, June 15<sup>th<\/sup> at 3:45 p.m. Eastern Time (12:45 p.m. Pacific Time).\n<\/p>\n<p>\nChromaDex management will also attend virtual one-on-one meetings with institutional investors throughout the day.\n<\/p>\n<p>\nWebcast link: <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwsw.com%2Fwebcast%2Foppenheimer22%2Fcdxc%2F2748608&amp;esheet=52742519&amp;newsitemid=20220607006148&amp;lan=en-US&amp;anchor=ChromaDex+Investor+Presentation+%26%238211%3B+Oppenheimer+Consumer+Conference&amp;index=1&amp;md5=f04f024e24dc5f5e5ccfedd9a161cec5\" rel=\"nofollow noopener\" shape=\"rect\">ChromaDex Investor Presentation \u2013 Oppenheimer Consumer Conference<\/a>\n<\/p>\n<p>\n<strong>About ChromaDex:<\/strong>\n<\/p>\n<p>\nChromaDex Corp. is a global bioscience company dedicated to healthy aging. The ChromaDex team, which includes world-renowned scientists, is pioneering research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. ChromaDex is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen\u00ae. Nicotinamide riboside and other NAD+ precursors are protected by ChromaDex\u2019s patent portfolio. ChromaDex delivers Niagen\u00ae as the sole active ingredient in its consumer product Tru Niagen\u00ae available at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.truniagen.com%2F&amp;esheet=52742519&amp;newsitemid=20220607006148&amp;lan=en-US&amp;anchor=www.truniagen.com&amp;index=2&amp;md5=01ce74ea0d6a75fe31630e917141dff0\" rel=\"nofollow noopener\" shape=\"rect\">www.truniagen.com<\/a> and through partnerships with global retailers and distributors. ChromaDex maintains a website at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.chromadex.com%2F&amp;esheet=52742519&amp;newsitemid=20220607006148&amp;lan=en-US&amp;anchor=www.chromadex.com&amp;index=3&amp;md5=08e6b2770215d0f6129286bd1131e0c5\" rel=\"nofollow noopener\" shape=\"rect\">www.chromadex.com<\/a> to which ChromaDex regularly posts copies of its press releases as well as additional and financial information about the Company.\n<\/p>\n<p>\n<b>Forward-Looking Statements:<\/b>\n<\/p>\n<p>\nThis release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities and Exchange Act of 1934, as amended. Statements that are not a description of historical facts constitute forward-looking statements and may often, but not always, be identified by the use of such words as &#8220;expects&#8221;, &#8220;anticipates&#8221;, &#8220;intends&#8221;, &#8220;estimates&#8221;, &#8220;plans&#8221;, &#8220;potential&#8221;, &#8220;possible&#8221;, &#8220;probable&#8221;, &#8220;believes&#8221;, &#8220;seeks&#8221;, &#8220;may&#8221;, &#8220;will&#8221;, &#8220;should&#8221;, &#8220;could&#8221; or the negative of such terms or other similar expressions. More detailed information about ChromaDex and the risk factors that may affect the realization of forward-looking statements is set forth in ChromaDex&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2021, ChromaDex&#8217;s Quarterly Reports on Form 10-Q and other filings submitted by ChromaDex to the SEC, copies of which may be obtained from the SEC&#8217;s website at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.sec.gov%2F&amp;esheet=52742519&amp;newsitemid=20220607006148&amp;lan=en-US&amp;anchor=www.sec.gov&amp;index=4&amp;md5=891ca1563318ae20d8a0303278c2b39f\" rel=\"nofollow noopener\" shape=\"rect\">www.sec.gov<\/a>. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof, and actual results may differ materially from those suggested by these forward-looking statements. All forward-looking statements are qualified in their entirety by this cautionary statement and ChromaDex undertakes no obligation to revise or update this release to reflect events or circumstances after the date hereof.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>ChromaDex Investor Relations Contact:<\/b><br \/>Brianna Gerber, Vice President of Finance and Investor Relations<br \/>\n<br \/>949-419-0288 ext. 127<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#105;l&#x74;&#x6f;&#58;br&#x69;&#x61;&#110;n&#x61;&#x67;&#64;&#99;h&#x72;&#x6f;&#109;a&#x64;&#x65;&#120;&#46;c&#x6f;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">bria&#110;&#110;&#97;&#103;&#64;&#99;&#104;&#x72;&#x6f;&#x6d;&#x61;&#x64;&#x65;&#x78;&#x2e;&#x63;om<\/a><\/p>\n<p><b>ChromaDex Media Contact:<\/b><br \/>Kendall Knysch, Director of Media Relations<br \/>\n<br \/>310-388-6706 ext. 689<br \/>\n<br \/><a target=\"_blank\" href=\"ma&#105;&#108;&#x74;&#x6f;&#x3a;&#x6b;en&#100;&#97;&#x6c;&#x6c;&#x2e;&#x6b;ny&#115;&#99;&#104;&#x40;&#x63;&#x68;&#x72;om&#97;&#100;&#x65;&#x78;&#x2e;&#x63;om\" rel=\"nofollow noopener\" shape=\"rect\">k&#101;&#110;&#x64;&#x61;&#x6c;l&#46;&#107;&#x6e;&#x79;&#x73;ch&#64;&#x63;&#x68;&#x72;om&#97;&#100;&#x65;&#x78;&#x2e;c&#111;&#109;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>LOS ANGELES&#8211;(BUSINESS WIRE)&#8211;$CDXC #Oppenheimer&#8211;ChromaDex Corp. (NASDAQ:CDXC) today announced that its Chief Executive Officer, Rob Fried, and Chief Financial Officer, Kevin Farr, will be presenting at Oppenheimer\u2019s 22nd Annual Consumer Growth and E-Commerce Conference. The ChromaDex management team is scheduled to present virtually on Wednesday, June 15th at 3:45 p.m. Eastern Time (12:45 p.m. Pacific Time). &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/chromadex-to-present-at-the-oppenheimers-22nd-annual-consumer-growth-and-e-commerce-conference\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-44813","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ChromaDex to Present at the Oppenheimer\u2019s 22nd Annual Consumer Growth and E-Commerce Conference - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/chromadex-to-present-at-the-oppenheimers-22nd-annual-consumer-growth-and-e-commerce-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ChromaDex to Present at the Oppenheimer\u2019s 22nd Annual Consumer Growth and E-Commerce Conference - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"LOS ANGELES&#8211;(BUSINESS WIRE)&#8211;$CDXC #Oppenheimer&#8211;ChromaDex Corp. (NASDAQ:CDXC) today announced that its Chief Executive Officer, Rob Fried, and Chief Financial Officer, Kevin Farr, will be presenting at Oppenheimer\u2019s 22nd Annual Consumer Growth and E-Commerce Conference. The ChromaDex management team is scheduled to present virtually on Wednesday, June 15th at 3:45 p.m. Eastern Time (12:45 p.m. Pacific Time). ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/chromadex-to-present-at-the-oppenheimers-22nd-annual-consumer-growth-and-e-commerce-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-07T18:01:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220607006148\/en\/784728\/21\/CDX_logo_horizontal-lrg-01_copy.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/chromadex-to-present-at-the-oppenheimers-22nd-annual-consumer-growth-and-e-commerce-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/chromadex-to-present-at-the-oppenheimers-22nd-annual-consumer-growth-and-e-commerce-conference\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"ChromaDex to Present at the Oppenheimer\u2019s 22nd Annual Consumer Growth and E-Commerce Conference\",\"datePublished\":\"2022-06-07T18:01:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/chromadex-to-present-at-the-oppenheimers-22nd-annual-consumer-growth-and-e-commerce-conference\\\/\"},\"wordCount\":463,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/chromadex-to-present-at-the-oppenheimers-22nd-annual-consumer-growth-and-e-commerce-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220607006148\\\/en\\\/784728\\\/21\\\/CDX_logo_horizontal-lrg-01_copy.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/chromadex-to-present-at-the-oppenheimers-22nd-annual-consumer-growth-and-e-commerce-conference\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/chromadex-to-present-at-the-oppenheimers-22nd-annual-consumer-growth-and-e-commerce-conference\\\/\",\"name\":\"ChromaDex to Present at the Oppenheimer\u2019s 22nd Annual Consumer Growth and E-Commerce Conference - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/chromadex-to-present-at-the-oppenheimers-22nd-annual-consumer-growth-and-e-commerce-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/chromadex-to-present-at-the-oppenheimers-22nd-annual-consumer-growth-and-e-commerce-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220607006148\\\/en\\\/784728\\\/21\\\/CDX_logo_horizontal-lrg-01_copy.jpg\",\"datePublished\":\"2022-06-07T18:01:26+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/chromadex-to-present-at-the-oppenheimers-22nd-annual-consumer-growth-and-e-commerce-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/chromadex-to-present-at-the-oppenheimers-22nd-annual-consumer-growth-and-e-commerce-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/chromadex-to-present-at-the-oppenheimers-22nd-annual-consumer-growth-and-e-commerce-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220607006148\\\/en\\\/784728\\\/21\\\/CDX_logo_horizontal-lrg-01_copy.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220607006148\\\/en\\\/784728\\\/21\\\/CDX_logo_horizontal-lrg-01_copy.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/chromadex-to-present-at-the-oppenheimers-22nd-annual-consumer-growth-and-e-commerce-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ChromaDex to Present at the Oppenheimer\u2019s 22nd Annual Consumer Growth and E-Commerce Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ChromaDex to Present at the Oppenheimer\u2019s 22nd Annual Consumer Growth and E-Commerce Conference - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/chromadex-to-present-at-the-oppenheimers-22nd-annual-consumer-growth-and-e-commerce-conference\/","og_locale":"en_US","og_type":"article","og_title":"ChromaDex to Present at the Oppenheimer\u2019s 22nd Annual Consumer Growth and E-Commerce Conference - Pharma Trend","og_description":"LOS ANGELES&#8211;(BUSINESS WIRE)&#8211;$CDXC #Oppenheimer&#8211;ChromaDex Corp. (NASDAQ:CDXC) today announced that its Chief Executive Officer, Rob Fried, and Chief Financial Officer, Kevin Farr, will be presenting at Oppenheimer\u2019s 22nd Annual Consumer Growth and E-Commerce Conference. The ChromaDex management team is scheduled to present virtually on Wednesday, June 15th at 3:45 p.m. Eastern Time (12:45 p.m. Pacific Time). ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/chromadex-to-present-at-the-oppenheimers-22nd-annual-consumer-growth-and-e-commerce-conference\/","og_site_name":"Pharma Trend","article_published_time":"2022-06-07T18:01:26+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220607006148\/en\/784728\/21\/CDX_logo_horizontal-lrg-01_copy.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/chromadex-to-present-at-the-oppenheimers-22nd-annual-consumer-growth-and-e-commerce-conference\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/chromadex-to-present-at-the-oppenheimers-22nd-annual-consumer-growth-and-e-commerce-conference\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"ChromaDex to Present at the Oppenheimer\u2019s 22nd Annual Consumer Growth and E-Commerce Conference","datePublished":"2022-06-07T18:01:26+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/chromadex-to-present-at-the-oppenheimers-22nd-annual-consumer-growth-and-e-commerce-conference\/"},"wordCount":463,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/chromadex-to-present-at-the-oppenheimers-22nd-annual-consumer-growth-and-e-commerce-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220607006148\/en\/784728\/21\/CDX_logo_horizontal-lrg-01_copy.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/chromadex-to-present-at-the-oppenheimers-22nd-annual-consumer-growth-and-e-commerce-conference\/","url":"https:\/\/pharma-trend.com\/en\/chromadex-to-present-at-the-oppenheimers-22nd-annual-consumer-growth-and-e-commerce-conference\/","name":"ChromaDex to Present at the Oppenheimer\u2019s 22nd Annual Consumer Growth and E-Commerce Conference - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/chromadex-to-present-at-the-oppenheimers-22nd-annual-consumer-growth-and-e-commerce-conference\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/chromadex-to-present-at-the-oppenheimers-22nd-annual-consumer-growth-and-e-commerce-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220607006148\/en\/784728\/21\/CDX_logo_horizontal-lrg-01_copy.jpg","datePublished":"2022-06-07T18:01:26+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/chromadex-to-present-at-the-oppenheimers-22nd-annual-consumer-growth-and-e-commerce-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/chromadex-to-present-at-the-oppenheimers-22nd-annual-consumer-growth-and-e-commerce-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/chromadex-to-present-at-the-oppenheimers-22nd-annual-consumer-growth-and-e-commerce-conference\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220607006148\/en\/784728\/21\/CDX_logo_horizontal-lrg-01_copy.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220607006148\/en\/784728\/21\/CDX_logo_horizontal-lrg-01_copy.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/chromadex-to-present-at-the-oppenheimers-22nd-annual-consumer-growth-and-e-commerce-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"ChromaDex to Present at the Oppenheimer\u2019s 22nd Annual Consumer Growth and E-Commerce Conference"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44813","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=44813"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44813\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=44813"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=44813"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=44813"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}